Peregrine Pharmaceuticals shares owned by Citigroup
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $997k | 153k | 6.50 |
| 2023-09-30 | $1.0M | 107k | 9.44 |
| 2023-03-31 | $3.2M | 170k | 18.75 |
| 2022-12-31 | $2.5M | 180k | 13.77 |
| 2022-09-30 | $3.6M | 187k | 19.12 |
| 2021-12-31 | $5.3M | 180k | 29.18 |
| 2021-03-31 | $78k | 4.3k | 18.21 |
| 2020-12-31 | $130k | 11k | 11.54 |
| 2020-09-30 | $23k | 3.0k | 7.56 |
| 2020-06-30 | $53k | 8.0k | 6.62 |
| 2020-03-31 | $87k | 17k | 5.09 |
| 2019-12-31 | $89k | 12k | 7.69 |
| 2019-09-30 | $40k | 7.5k | 5.36 |
| 2019-06-30 | $89k | 16k | 5.56 |
| 2019-03-31 | $60k | 14k | 4.25 |
| 2018-12-31 | $54k | 13k | 4.08 |
| 2018-09-30 | $98k | 14k | 6.85 |
| 2018-06-30 | $31k | 7.7k | 3.98 |
| 2018-03-31 | $1.0k | 443 | 2.26 |